ET
Ectica Technologies
Ectica Technologies provides synthetic hydrogel platforms and pre‑developed ex‑vivo tumor‑stroma models for oncology, fibrosis and tissue‑regeneration research. Their 3DProSeed® StromaLine enables high‑content screening of drug candidates in physiologically relevant tumor‑microenvironment assays. The company also offers custom hydrogel development, manufacturing, and characterization services for CROs and biopharma partners.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Ectica Technologies provides synthetic hydrogel platforms and pre‑developed ex‑vivo tumor‑stroma models for oncology, fibrosis and tissue‑regeneration research. Their 3DProSeed® StromaLine enables high‑content screening of drug candidates in physiologically relevant tumor‑microenvironment assays. The company also offers custom hydrogel development, manufacturing, and characterization services for CROs and biopharma partners.